Our profiling and comparison from the actions of conolidine and cannabidiol with recognized pharmacological agents predicted a MOA shared with Cav2.2 channel blocker, ω-conotoxin CVIE. In 2011, the halls in the Scripps Research Institute in Jupiter, Florida witnessed the inception of a scientific journey that could redefine our understanding https://louisi405euk0.eqnextwiki.com/user